Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$244.67 USD

244.67
11,341,591

-1.11 (-0.45%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $244.50 -0.17 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 1% (243 out of 246)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Zacks Equity Research

The Zacks Analyst Blog Highlights UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt

by Zacks Equity Research

UnitedHealth, Chevron, AstraZeneca, SAP and Bayer ktiengesellschaftt are part of Zacks top Analyst Blog.

Mark Vickery headshot

Top Analyst Reports for UnitedHealth, Chevron & AstraZeneca

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Chevron Corporation (CVX), and AstraZeneca PLC (AZN).

Zacks Equity Research

Select Medical (SEM), Inova Health Form JV in Northern Virginia

by Zacks Equity Research

The JV between Select Medical (SEM) and Inova Health System is expected to own and operate a new 32-bed critical illness recovery facility.

Zacks Equity Research

UnitedHealth Group (UNH) Boasts Earnings & Price Momentum: Should You Buy?

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Zacks Equity Research

Why You Should Retain Humana (HUM) in Your Portfolio Now

by Zacks Equity Research

Humana's (HUM) strategic acquisitions help it boost its footprint and expand the product portfolio.

Zacks Equity Research

UnitedHealth (UNH) Unit Unveils Solution to Provide Better Care

by Zacks Equity Research

UnitedHealth's (UNH) subsidiary Optum introduces a solution that can detect tests that are clinically backed, thereby minimizing unrequired tests and offering enhanced care to health plan members.

Zacks Equity Research

UnitedHealth Group (UNH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $489.68 in the latest trading session, marking a +1.95% move from the prior day.

Zacks Equity Research

Centene (CNC) Stock Jumps 6%: Will It Continue to Soar?

by Zacks Equity Research

Centene (CNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Zacks Equity Research

UnitedHealth (UNH) Unit Eyes $1.5B EMIS Acquisition in UK

by Zacks Equity Research

UnitedHealth's (UNH) Optum business operates in the United Kingdom for two decades and the acquisition is expected to boost its footprint in the country.

Zacks Equity Research

Encompass Health (EHC) Opens EHR-Backed Hospital in Florida

by Zacks Equity Research

Encompass Health (EHC) takes its U.S. inpatient rehabilitation hospital count to 150 with the opening of a hospital in Florida integrated with the sound EHR system of Oracle Cerner.

Zacks Equity Research

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

by Zacks Equity Research

Sector ETF report for PTH

Zacks Equity Research

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, UnitedHealth Group (UNH) closed at $464.33, marking a +0.56% move from the previous day.

Zacks Equity Research

Humana (HUM) Unveils Transition of Units to CenterWell Brand

by Zacks Equity Research

Humana (HUM) announces the rebranding of its pharmacy divisions to the CenterWell brand, reflecting the rapid expansion initiatives to grow the brand and better serve members.

Zacks Equity Research

LabCorp (LH) Rides on Innovations Amid Cost Constraints

by Zacks Equity Research

LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.

Zacks Equity Research

Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for PFM

Zacks Equity Research

Here's Why You Should Retain Boston Scientific (BSX) for Now

by Zacks Equity Research

Investors are optimistic about Boston Scientific's (BSX) strong organic sales and notable acquisitions.

Zacks Equity Research

Abbott (ABT) Medical Devices Arm Gains Traction, FX Woe Stays

by Zacks Equity Research

Within Abbott's (ABT) Nutrition arm, while the pediatric nutrition business witnesses a drag, the adult nutrition business continues to perform well.

Zacks Equity Research

Amedisys (AMED) Contessa's New JV Broadens At-Home Care Range

by Zacks Equity Research

Amedisys' (AMED) latest initiative aims at providing patients with a high-quality continuum of care in the home.

Zacks Equity Research

Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod

by Zacks Equity Research

Thermo Fisher's (TMO) RNA Polymerase III and EliA Rib-P blood tests are intended to diagnose systemic sclerosis and systemic lupus erythematosus.

Zacks Equity Research

UnitedHealth (UNH) Rewards Shareholders With 13.8% Dividend Hike

by Zacks Equity Research

UnitedHealth's (UNH) strong balance sheet supports its endeavors to return shareholders' funds.

Zacks Equity Research

Here's Why Investors Should Retain Alcon (ALC) Stock For Now

by Zacks Equity Research

Investors are optimistic about Alcon's (ALC) better-than-expected results and robust performance across its popular franchises.

Zacks Equity Research

Thermo Fisher (TMO) to Promote Mass Spectrometry Imaging

by Zacks Equity Research

Thermo Fisher's (TMO) new deal with TransMIT will advance the use of the AP-SMALDI5 AF ion source with Orbitrap MS technology for spatial multi-omics applications.

Zacks Equity Research

PerkinElmer's (PKI) Latest Launch to Expand Food Safety Suite

by Zacks Equity Research

PerkinElmer's (PKI) microbial plates minimize human error by providing standardized protocols and offer a small footprint to save space in incubators and storage areas.

Zacks Equity Research

Henry Schein (HSIC) Inks New Deal to Acquire Condor Dental

by Zacks Equity Research

Henry Schein's (HSIC) acquisition of a Switzerland-based dental distribution company will strengthen its presence in the attractive European market.

Zacks Equity Research

Bruker (BRKR) to Advance 4D Proteomics With Latest Launch

by Zacks Equity Research

Bruker's (BRKR) timsTOF HT is enhanced for high-throughput, deep and unbiased plasma proteomics, and liquid biopsy biomarker research.